28 results
8-K
EX-99.1
CSTL
Castle Biosciences Inc
8 Jan 24
Results of Operations and Financial Condition
7:04am
and overall mortality relative to untested patients Bailey et al. JCO PO, 2023. ‡Hazard ra o (HR) was computed using the untested pa ents as reference … to deep invasion, poor differentiation or PNI 0 5 10 Hazard Ratio 0 5 Hazard Ratio Immunosuppression Tumor diameter (per cm) Perineural invasion Deep
8-K
EX-99.2
CSTL
Castle Biosciences Inc
2 Nov 23
Castle Biosciences Reports Third Quarter 2023 Results
4:09pm
relative to untested patients Bailey et al. JCO PO, 2023. ‡Hazard ra o (HR) was computed using the untested pa ents as reference for 31-GEP tested cohort … differentiation or PNI 0 5 10 Hazard Ratio 0 5 Hazard Ratio Immunosuppression Tumor diameter (per cm) Perineural invasion Deep invasion Poor
8-K
EX-99.2
CSTL
Castle Biosciences Inc
2 Aug 23
Castle Biosciences Reports Second Quarter 2023 Results
4:10pm
was associated with lower melanoma-specific and overall mortality relative to untested patients Bailey et al. JCO PO, 2023. ‡Hazard ratio (HR … % (57/3258) Matched Untested 96.1% (95.5-96.6%) 2.5% (242/9774) Hazard Ratio 0.71 (0.53-0.94) p=0.018 Group 3-year OS (95% Cl) Deaths, % (n/N) 31-GEP
8-K
EX-99.2
CSTL
Castle Biosciences Inc
2 Nov 22
Castle Biosciences Announces Third Quarter 2022 Results
4:24pm
% (90.4-91.9%) 6.1% (658/10,863) Hazard Ratio‡ 0.79 (0.67-0.93) P=0.006 3-year OS (95% CI) Deaths, % (n/N) Benefit in Overall Survival (OS … % (238/10,863) Hazard Ratio‡ 0.73 (0.54-0.97) P=0.03 3-year MSS (95% CI) Deaths, % (n/N) Benefit in Melanoma Specific Survival (MSS) in patients who were
8-K
EX-99.2
np0x0i f7
8 Aug 22
Castle Biosciences Reports Second Quarter 2022 Results
4:12pm
8-K
EX-99.1
spu93 qe6
8 Aug 22
Castle Biosciences Reports Second Quarter 2022 Results
4:12pm
8-K
EX-99.2
v4a5kt25
9 May 22
Castle Biosciences Reports First Quarter 2022 Results
4:19pm
8-K
EX-99.1
hz9q34
9 May 22
Castle Biosciences Reports First Quarter 2022 Results
4:19pm
8-K
EX-99.2
zlr0q wwq2o5t
10 Jan 22
Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2021 Results
7:03am
8-K
EX-99.2
1raf 67lu18hmow
8 Nov 21
Castle Biosciences Announces Third Quarter 2021 Results
4:11pm
8-K
EX-99.2
8sb crerfdvr9v8n
9 Aug 21
Castle Biosciences Announces Second Quarter 2021 Results
4:14pm
8-K
EX-99.2
leys ecb7
10 May 21
Castle Biosciences Announces First Quarter 2021 Results
4:11pm
8-K
EX-99.2
l0wizk9te9he jc8yzyd
8 Mar 21
Castle Biosciences Announces Fourth Quarter and Full-Year 2020 Results
4:09pm
8-K
EX-99.2
xadzov9
13 Jan 21
Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2020 Results
7:04am
8-K
EX-99.1
nnnd8k9htiua77d
14 Dec 20
Other Events
4:04pm
8-K
EX-99.1
p9k0x
15 Apr 20
Regulation FD Disclosure
7:59am